2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$17.61-$0.20 (-1.12%)
Price as of Nov 12, 2026 8:07 AM EST- $968.3MMarket Cap
- -36.75%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$17.61-$0.20 (-1.12%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.81 | ||
Change | +$1.29 (+7.81%) | ||
Open | $16.77 | ||
High | $17.91 | ||
Low | $16.77 | ||
Previous Close | $16.52 | ||
Volume | 913,854 | ||
30-Day Average Volume | 1,191,917 | ||
1-Week Change | 5.07% | ||
1-Month Change | 1.02% | ||
1-Year Change | -36.75% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 54.4M | ||
Total Assets | $443.8M | ||
Market Cap | $968.3M | ||
Enterprise Value | $886.7M | ||
Period: QTR TTM FY | |||
Revenue | $35.5M | ||
Net Income | -$24.4M | ||
Free Cash Flow | -$14.6M | ||
EBIT | -$24.4M | ||
EBITDA | -$23.5M | ||
Net Working Capital | $260.1M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 2 | ||
P/E | -34 | ||
PEG | -18 | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -79 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue